Plasma-derived protein and imaging biomarkers distinguish disease severity in oculopharyngeal muscular dystrophy
The candidate biomarkers identified contribute to the ongoing search for sensitive and accessible biomarkers of OPMD progression, prognosis, and monitoring.
Authors
- Pierre R. Bourque (ORCID: https://orcid.org/0000-0002-7455-0254)
- Jodi Warman‐Chardon (ORCID: https://orcid.org/0000-0002-0187-2199)
- Theodore J. Perkins (ORCID: https://orcid.org/0000-0002-6622-8003)
- Mireille Khacho (ORCID: https://orcid.org/0000-0002-5936-1615)
- Marcos Loreto Sampaio (ORCID: https://orcid.org/0000-0002-4081-0169)
- Cameron Stotts
- Hanns Lochmüller (ORCID: https://orcid.org/0000-0003-2324-8001)
- Omar Ayoub
- Gerd Melkus (ORCID: https://orcid.org/0000-0001-5387-8958)
- Kaitlynn Meier-Ross
- Shaoni Chakraborty
- Ian C. P. Smith (ORCID: https://orcid.org/0000-0001-5269-1710)
- Bernard Brais
Institutions
- Montreal Neurological Institute and Hospital (CA)
- University of Ottawa (CA)
- Children's Hospital of Eastern Ontario (CA)
- Ottawa Hospital (CA)
- Ottawa Hospital Research Institute (CA)
- McGill University (CA)
- Carleton University (CA)
Publication Details
- Journal
- Journal of Neuromuscular Diseases
- Published
- 2024-12-20
- DOI
- https://doi.org/10.1177/22143602241304990
- Citations
- 2
- Primary Topic
- Muscle Physiology and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.47